Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-14T04:23:59.520Z Has data issue: false hasContentIssue false
  • English
  • Français

The Costs of Healthcare Worker Respiratory Protection and Fit-Testing Programs

Published online by Cambridge University Press:  02 January 2015

Scott E. Kellerman ,
Jerome I. Tokars  and
William R. Jarvis
Scott E. Kellerman*
Affiliation:
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia
Jerome I. Tokars
Affiliation:
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia
William R. Jarvis
Affiliation:
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop E69, Atlanta, GA 30333; e-mail, sek0@cdc.gov.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We studied hospital costs associated with healthcare worker (HCW) respiratory protection and respirator fit-testing programs recommended by the Centers for Disease Control and Prevention (CDC) and mandated by the Occupational Safety and Health Administration to decrease nosocomial or occupational Mycobacterium tuberculosis (TB).

Design:

The number and cost of high-efficiency particulate air (HEPA)-filter and dust-mist (DM) respirators for 1989 to 1994 were obtained from study hospital purchasing departments, and the costs of HCW fit-testing and education programs for 1994 were estimated from information provided by infection control practitioners. Costs of N-class respirator programs were estimated for study hospitals using retrospective cost analysis and an observational study.

Setting:

Four urban hospitals with, and one rural community hospital without, documented nosocomial or occupational transmission of multidrug-resistant TB.

Results:

During the study period, four of five hospitals introduced HEPA and DM respirators and respirator education and fit-testing programs. Median costs in 1994 were $83,900 (range, $2,000-$223,000) for respirators and $17,187 (range, $8,736-$26,175) for respiratory fit-testing programs. The projected median annual cost of N95 respirators was $62,023 (range, $270-$422,526).

Conclusions:

Compliance with CDC TB guidelines may require a substantial investment. However, outlays for respirators and education and fit-testing programs are more reasonable than would be suggested by analyses that estimated the costs of preventing one case of nosocomial TB

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 19 , Issue 9 , September 1998 , pp. 629 - 634
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention. Draft guidelines for preventing the transmission of tuberculosis in health-care facilities, second edition: notice of comment period. Federal Register 1993;58(195):52810–52854.Google Scholar
2. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, 1994. MMWR 1994;43(RR-13).Google Scholar
3. Adal, KA, Anglim, AM, Palumbo, CL, Titus, MG, Coyner, BJ, Farr, BM. The use of high-efficiency particulate air filter respirators to protect hospital workers from tuberculosis. N Engl J Med 1994;331:169–173.CrossRefGoogle ScholarPubMed
4. Nettleman, MD, Fredrickson, M, Good, NL, Hunter, SA. Tuberculosis control strategies: the cost of particulate respirators. Ann Intern Med 1994;121:37–40.CrossRefGoogle ScholarPubMed
5. Fella, P, Rivera, P, Hale, M, Squires, K, Sepkowitz, K. Dramatic decrease in tuberculin skin test conversion rate among employees at a hospital in New York City. Am J Infect Control 1995;23:352–356.CrossRefGoogle Scholar
6. Edlin, BR, Tokars, JI, Grieco, MH, Crawford, JT, Williams, J, Sordillo, EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514–1521.CrossRefGoogle ScholarPubMed
7. Pearson, ML, Jereb, JA, Frieden, TR, Crawford, JT, Davis, BJ, Dooley, SW, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and healthcare workers. Ann Intern Med 1992;117:191–196.CrossRefGoogle Scholar
8. Jereb, JA, Klevens, M, Privett, TD, Smith, PJ, Crawford, JT, Sharp, VL, et al. Tuberculosis in healthcare workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis . Arch Intern Med 1995;155(8):854–859.CrossRefGoogle Scholar
9. Beck-Sague, C, Dooley, SW, Huttun, MD, Otten, J, Breeden, A, Crawford, JT, et al. Hospital outbreaks of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280–1286.CrossRefGoogle ScholarPubMed
10. Jarvis, WR, Bolyard, EA, Bozzi, CJ, Burwen, DR, Dooley, SW, Martin, LS, et al. Respirators, recommendations, and regulations: the controversy surrounding protection of healthcare workers from tuberculosis. Ann Intern Med 1995;122:142–146.CrossRefGoogle ScholarPubMed
11. Sobel, E. HEPA respirators and tuberculosis in hospital workers. N Engl J Med 1994;331:1658–1659. Letter.Google ScholarPubMed
12. Chen, S-K, Vesley, D, Brousseau, LM, Vincent, JH. Evaluation of single-use masks and respirators for protection of healthcare workers against mycobacterial aerosols. Am J Infect Control 1994;22:65–74.CrossRefGoogle ScholarPubMed
13. Department of Health and Human Services. Notice of proposed rule-making on respiratory protection devices. Health-care-facility workers potentially exposed to tuberculosis (42 CFR 84). Federal Register 1994;59(99):26850–26889.Google Scholar
14. Department of Health and Human Services. Final notice on respiratory protective devices. Federal Register 1995;60(110):30336–30404.Google Scholar
15. Wenger, PN, Otten, J, Breeden, A, Orfas, D, Beck-Sague, CM, Jarvis, WJ. Control of nosocomial transmission of multidrug-resistant Mycobacteri-um tuberculosis among healthcare workers and HIV-infected patients. Lancet 1995;345:235–240.CrossRefGoogle ScholarPubMed
16. Stroud, LA, Tokars, JI, Grieco, MH, Crawford, JT, Culver, DH, Edlin, BR, et al. Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City Hospital. Infect Control Hosp Epidemiol 1995;16:141–147.CrossRefGoogle Scholar
17. Maloney, SA, Pearson, ML, Gordon, MT, Del Castillo, R, Boyle, JF, Jarvis, WR. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and healthcare workers. Ann Intern Med 1995;122:90–95.CrossRefGoogle Scholar
18. Kenyon, TA, Ridzon, R, Luskin-Hawk R, Schultz, C, Paul, WS, Valway, SE, et al. A nosocomial outbreak of multidrug-resistant tuberculosis. Ann Intern Med 1987;127:32–36.CrossRefGoogle Scholar
19. Nicas, M. Respiratory protection and the risk of Mycobacterium tuberculosis infection . Am J Ind Med 1995;27:317–333.CrossRefGoogle ScholarPubMed
20. Barnhart, S, Sheppard, L, Beaudet, N, Stover, B, Balmes, J. Tuberculosis in healthcare settings and the estimated benefits of engineering controls and respiratory protection. J Occup Environ Med 1997;39:849–854.CrossRefGoogle Scholar